Comments

BioXcel Therapeutics

BTAINASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.576600
-0.08-12.13%
At Close: -
$0.585500
0.00891.54%
After Hours: Sep 20, 7:59 PM EDT
15 minutes delayed
BioXcel Therapeutics (BTAI) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

BioXcel Therapeutics (NASDAQ:BTAI) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for BioXcel Therapeutics (BTAI)?

A

There have been no specific sales or earnings guidance reported for BioXcel Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch